BioCentury | May 17, 2018
Finance

Europe’s piece of the pie

...Ltd., launched in 2016, has the siRNA candidate JT-02 targeting CLDN5 and OCLN. Norwegian company Pharmasum Therapeutics A/S...
...Novo Holdings A/S, Hellerup, Denmark Orchard Therapeutics Ltd., London, U.K. Orexo AB (SSE:ORX), Uppsala, Sweden Pharmasum Therapeutics A/S...
BioCentury | Nov 16, 2017
Translation in Brief

Lighting up the DYRK

...and the compound is available for licensing. Two other companies have DYRK1A inhibitors in development. Pharmasum Therapeutics A/S...
...the National Academy of Sciences (2017) Winnie Pong and Mark Zipkin, Staff Writers NNI-351 Kyoto University ManRos Therapeutics S.A. NeuroNascent Inc. Pharmasum Therapeutics A/S Dual-specificity...
BioCentury | Sep 19, 2017
Distillery Therapeutics

Neurology

...a small molecule DYRK1A inhibitor, in preclinical testing for depression and post-traumatic stress disorder (PTSD). Pharmasum Therapeutics A/S...
BioCentury | Jan 7, 2016
Distillery Therapeutics

Therapeutics: Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A); glycogen synthase kinase 3β (GSK3β)

...compound alone. Next steps could include developing more selective dual inhibitors of DYRK1A and GSK3β. Pharmasum Therapeutics A/S...
BioCentury | Jul 20, 2015
Emerging Company Profile

Shot in the DYRK

...cancer cells. At least one other company is developing DYRK inhibitors, but not in oncology. Pharmasum Therapeutics A/S...
...and molecules. Companies and Institutions Mentioned Diaxonhit (Euronext:ALEHT), Paris, France Felicitex Therapeutics Inc., Cambridge, Mass. Pharmasum Therapeutics A/S...
BioCentury | May 12, 2014
Emerging Company Profile

Pharmasum: Down with AD

...Tromso, Norway Pharmasum Therapeutics A/S , Oslo, Norway Research Council of Norway , Oslo, Norway Sidebars Pharmasum Therapeutics A/S...
BioCentury | Apr 21, 2014
Company News

Lytix, Pharmasum Therapeutics neurology news

...that is in Phase II testing to treat impetigo. Lytix Biopharma A/S , Tromso, Norway Pharmasum Therapeutics A/S...
Items per page:
1 - 7 of 7
BioCentury | May 17, 2018
Finance

Europe’s piece of the pie

...Ltd., launched in 2016, has the siRNA candidate JT-02 targeting CLDN5 and OCLN. Norwegian company Pharmasum Therapeutics A/S...
...Novo Holdings A/S, Hellerup, Denmark Orchard Therapeutics Ltd., London, U.K. Orexo AB (SSE:ORX), Uppsala, Sweden Pharmasum Therapeutics A/S...
BioCentury | Nov 16, 2017
Translation in Brief

Lighting up the DYRK

...and the compound is available for licensing. Two other companies have DYRK1A inhibitors in development. Pharmasum Therapeutics A/S...
...the National Academy of Sciences (2017) Winnie Pong and Mark Zipkin, Staff Writers NNI-351 Kyoto University ManRos Therapeutics S.A. NeuroNascent Inc. Pharmasum Therapeutics A/S Dual-specificity...
BioCentury | Sep 19, 2017
Distillery Therapeutics

Neurology

...a small molecule DYRK1A inhibitor, in preclinical testing for depression and post-traumatic stress disorder (PTSD). Pharmasum Therapeutics A/S...
BioCentury | Jan 7, 2016
Distillery Therapeutics

Therapeutics: Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A (DYRK1A); glycogen synthase kinase 3β (GSK3β)

...compound alone. Next steps could include developing more selective dual inhibitors of DYRK1A and GSK3β. Pharmasum Therapeutics A/S...
BioCentury | Jul 20, 2015
Emerging Company Profile

Shot in the DYRK

...cancer cells. At least one other company is developing DYRK inhibitors, but not in oncology. Pharmasum Therapeutics A/S...
...and molecules. Companies and Institutions Mentioned Diaxonhit (Euronext:ALEHT), Paris, France Felicitex Therapeutics Inc., Cambridge, Mass. Pharmasum Therapeutics A/S...
BioCentury | May 12, 2014
Emerging Company Profile

Pharmasum: Down with AD

...Tromso, Norway Pharmasum Therapeutics A/S , Oslo, Norway Research Council of Norway , Oslo, Norway Sidebars Pharmasum Therapeutics A/S...
BioCentury | Apr 21, 2014
Company News

Lytix, Pharmasum Therapeutics neurology news

...that is in Phase II testing to treat impetigo. Lytix Biopharma A/S , Tromso, Norway Pharmasum Therapeutics A/S...
Items per page:
1 - 7 of 7